MedPath

Qom University of Medical Sciences

Qom University of Medical Sciences logo
Iran
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.muq.ac.ir

Clinical Trials

28

Active:0
Completed:26

Trial Phases

3 Phases

Phase 2:3
Phase 3:3
Not Applicable:22

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials

Not Applicable
22 (78.6%)
Phase 2
3 (10.7%)
Phase 3
3 (10.7%)

Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome

Phase 2
Completed
Conditions
Irritable Bowel Syndrome
Interventions
First Posted Date
2010-12-31
Last Posted Date
2010-12-31
Lead Sponsor
Qom University of Medical Sciences
Registration Number
NCT01268709
Locations
🇮🇷

Gastrointestinal Research center,Beheshti Hospital, Qom, Iran, Islamic Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.